Immix Biopharma (IMMX) Depreciation & Amortization (CF) (2021 - 2026)
Quarterly results put Depreciation & Amortization (CF) at $91577.0 for Q1 2026, up 140.03% from a year ago — trailing twelve months through Mar 2026 was $299171.0 (up 339.41% YoY), and the annual figure for FY2025 was $245747.0, up 646.02%.
Immix Biopharma has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $91577.0 for Q1 2026.
- Depreciation & Amortization (CF) reached $91577.0 in Q1 2026 per IMMX's latest filing, up from $52114.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $96986.0 in Q3 2025 and bottomed at $383.0 in Q2 2022.
- Median Depreciation & Amortization (CF) over the past 5 years was $3076.0 (2023), compared with a mean of $22227.5.
- The largest annual shift saw Depreciation & Amortization (CF) plummeted 38.23% in 2022 before it surged 1679.89% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $566.0 in 2022, then soared by 443.46% to $3076.0 in 2023, then skyrocketed by 569.8% to $20603.0 in 2024, then soared by 152.94% to $52114.0 in 2025, then soared by 75.72% to $91577.0 in 2026.
- Business Quant data shows Depreciation & Amortization (CF) for IMMX at $91577.0 in Q1 2026, $52114.0 in Q4 2025, and $96986.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 123.20 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | 91,577.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,577.00 |
| Mar 31, 2026 | 91,577.00 |
| Dec 31, 2025 | 52,114.00 |
| Dec 31, 2025 | 52,114.00 |
| Sep 30, 2025 | 96,986.00 |
| Sep 30, 2025 | 96,986.00 |
| Jun 30, 2025 | 58,494.00 |
| Jun 30, 2025 | 58,494.00 |
| Mar 31, 2025 | 38,153.00 |
| Mar 31, 2025 | 38,153.00 |
| Dec 31, 2024 | 20,603.00 |
| Dec 31, 2024 | 20,603.00 |
| Sep 30, 2024 | 5,449.00 |
| Sep 30, 2024 | 5,449.00 |
| Jun 30, 2024 | 3,879.00 |
| Jun 30, 2024 | 3,879.00 |
| Mar 31, 2024 | 3,010.00 |
| Mar 31, 2024 | 3,010.00 |
| Dec 31, 2023 | 3,076.00 |
| Dec 31, 2023 | 3,076.00 |
| Sep 30, 2023 | 1,381.00 |
| Sep 30, 2023 | 1,381.00 |
| Jun 30, 2023 | 506.00 |
| Jun 30, 2023 | 506.00 |
| Mar 31, 2023 | 505.00 |
| Mar 31, 2023 | 505.00 |
| Dec 31, 2022 | 566.00 |
| Dec 31, 2022 | 566.00 |
| Sep 30, 2022 | 566.00 |
| Sep 30, 2022 | 566.00 |
| Jun 30, 2022 | 383.00 |
| Jun 30, 2022 | 383.00 |
| Mar 31, 2022 | 620.00 |
| Mar 31, 2022 | 620.00 |
| Dec 31, 2021 | 620.00 |
| Dec 31, 2021 | 620.00 |
| Sep 30, 2021 | 620.00 |
| Sep 30, 2021 | 620.00 |
| Jun 30, 2021 | 620.00 |
| Jun 30, 2021 | 620.00 |
| Mar 31, 2021 | 608.00 |
| Mar 31, 2021 | 608.00 |